These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 20522375

  • 1. HPV test shows low sensitivity of Pap screen in older women.
    Gyllensten U, Lindell M, Gustafsson I, Wilander E.
    Lancet Oncol; 2010 Jun; 11(6):509-10; author reply 510-1. PubMed ID: 20522375
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

  • 3. HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
    Wright TC.
    Int J Gynaecol Obstet; 2006 Nov 09; 95 Suppl 1():S239-46. PubMed ID: 17161163
    [No Abstract] [Full Text] [Related]

  • 4. [HPV test replaces Pap test in Uppsala].
    Olovsson M, Aarnio R, Rezapour M, Segeblad B, Sjöö EL, Wilander E.
    Lakartidningen; 2006 Nov 09; 110(13-14):695-6. PubMed ID: 23634626
    [No Abstract] [Full Text] [Related]

  • 5. Role of HPV-assay as an adjuvant to Pap's smear for diagnosis of carcinoma cervix.
    Shahi SK, Ranga S, Srivastava R.
    Indian J Pathol Microbiol; 2000 Oct 09; 43(4):383-5. PubMed ID: 11344599
    [No Abstract] [Full Text] [Related]

  • 6. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan 09; 41(1):34-7. PubMed ID: 16635326
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M, Del Mistro A, Farruggio A, de'Bartolomeis L, Frayle-Salamanca H, Baboci L, Bertazzo A, Cocco P, Fedato C, Gennaro M, Marchi N, Penon MG, Cogo C, Ferro A.
    BJOG; 2013 Sep 09; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular screening for cervical cancer--time to give up Pap tests?
    Runowicz CD.
    N Engl J Med; 2007 Oct 18; 357(16):1650-3. PubMed ID: 17942878
    [No Abstract] [Full Text] [Related]

  • 14. Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics.
    Dannecker C, Siebert U, Thaler CJ, Kiermeir D, Hepp H, Hillemanns P.
    Ann Oncol; 2004 Jun 18; 15(6):863-9. PubMed ID: 15151941
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Benefits and costs of using HPV testing to screen for cervical cancer.
    Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K.
    JAMA; 2002 May 08; 287(18):2372-81. PubMed ID: 11988058
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.
    Fields RP.
    N Engl J Med; 2008 Feb 07; 358(6):642-3; author reply 643-4. PubMed ID: 18265442
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.